|
1
|
Boye E, Jinnin M and Olsen BR: Infantile
hemangioma: Challenges, new insights, and therapeutic promise. J
Craniofac Surg. 20(Suppl 1): S678–S684. 2009. View Article : Google Scholar
|
|
2
|
Haggstrom AN, Drolet BA, Baselga E,
Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW,
Newell B, et al: Prospective study of infantile hemangiomas:
Clinical characteristics predicting complications and treatment.
Pediatrics. 118:882–887. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao F, Yang X, Xu G, Bi J, Lv R and Huo
R: Propranolol suppresses HUVEC viability, migration, VEGF
expression, and promotes apoptosis by downregulation of miR-4295. J
Cell Biochem. 120:6614–6623. 2019. View Article : Google Scholar
|
|
4
|
Zhang K, Wang F, Huang J, Lou Y, Xie J, Li
H, Cao D and Huang X: Insulin-like growth factor 2 promotes the
adipogenesis of hemangioma-derived stem cells. Exp Ther Med.
17:1663–1669. 2019.PubMed/NCBI
|
|
5
|
Khan ZA, Boscolo E, Picard A, Psutka S,
Melero-Martin JM, Bartch TC, Mulliken JB and Bischoff J:
Multipotential stem cells recapitulate human infantile hemangioma
in immunodeficient mice. J Clin Invest. 118:2592–2599.
2008.PubMed/NCBI
|
|
6
|
Wang F, Li H, Lou Y, Xie J, Cao D and
Huang X: Insulinlike growth factor I promotes adipogenesis in
hemangioma stem cells from infantile hemangiomas. Mol Med Rep.
19:2825–2830. 2019.PubMed/NCBI
|
|
7
|
Chen Q, Shou P, Zheng C, Jiang M, Cao G,
Yang Q, Cao J, Xie N, Velletri T, Zhang X, et al: Fate decision of
mesenchymal stem cells: Adipocytes or osteoblasts. Cell Death
Differ. 23:1128–1139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tontonoz P, Hu E and Spiegelman BM:
Regulation of adipocyte gene expression and differentiation by
peroxisome proliferator activated receptor gamma. Curr Opin Genet
Dev. 5:571–576. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao P, Deng Y, Gu P, Wang Y, Zhou H, Hu
Y, Chen P and Fan X: Insulin-like growth factor 1 promotes the
proliferation and adipogenesis of orbital adipose-derived stromal
cells in thyroid-associated ophthalmopathy. Exp Eye Res. 107:65–73.
2013. View Article : Google Scholar
|
|
10
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kasinski AL and Slack FJ: Epigenetics and
genetics MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Treiber T, Treiber N and Meister G:
Regulation of microRNA biogenesis and function. Thromb Haemost.
107:605–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye Y, Song Y, Zhuang J, Wang G, Ni J,
Zhang S and Xia W: MicroRNA-302a-3p suppresses hepatocellular
carcinoma progression by inhibiting proliferation and invasion.
Onco Targets Ther. 11:8175–8184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L, Dai J, Li F, Cheng H, Yan D and
Ruan Q: The expression and function of miR-424 in infantile skin
hemangioma and its mechanism. Sci Rep. 7:118462017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang Z, Bian C, Zhou H, Huang S, Wang S,
Liao L and Zhao RC: MicroRNA hsa-miR-138 inhibits adipogenic
differentiation of human adipose tissue-derived mesenchymal stem
cells through adenovirus EID-1. Stem Cells Dev. 20:259–267. 2011.
View Article : Google Scholar
|
|
16
|
Xu W, Hang M, Yuan C, Wu F, Chen S and Xue
K: MicroRNA-139-5p inhibits cell proliferation and invasion by
targeting insulin-like growth factor 1 receptor in human non-small
cell lung cancer. Int J Clin Exp Pathol. 8:3864–3870.
2015.PubMed/NCBI
|
|
17
|
Yuan SM, Guo Y, Zhou XJ, Shen WM and Chen
HN: PDGFR-β (+) perivascular cells from infantile hemangioma
display the features of mesenchymal stem cells and show stronger
adipogenic potential in vitro and in vivo. Int J Clin Exp Patho.
7:2861–2870. 2014.
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta DeltaC(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Yu Y, Fuhr J, Boye E, Gyorffy S, Soker S,
Atala A, Mulliken JB and Bischoff J: Mesenchymal stem cells and
adipogenesis in hemangioma involution. Stem Cells. 24:1605–1612.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boney CM, Gruppuso PA, Faris RA and
Frackelton AR Jr: The critical role of Shc in insulin-like growth
factor-I-mediated mitogenesis and differentiation in 3T3-L1
preadipocytes. Mol Endocrinol. 14:805–813. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Boney CM, Smith RM and Gruppuso PA:
Modulation of insulin-like growth factor I mitogenic signaling in
3T3-L1 preadipocyte differentiation. Endocrinology. 139:1638–1644.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith PJ, Wise LS, Berkowitz R, Wan C and
Rubin CS: Insulin-like growth factor-I is an essential regulator of
the differentiation of 3T3-L1 adipocytes. J Biol Chem.
263:9402–9408. 1988.PubMed/NCBI
|
|
23
|
Schmid C, Steiner T and Froesch ER:
Insulin-like growth factor I supports differentiation of cultured
osteoblast-like cells. FEBS Lett. 173:48–52. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mcmorris FA, Smith TM, Desalvo S and
Furlanetto RW: Insulin-like growth factor I/somatomedin C: A potent
inducer of oligodendrocyte development. Proc Natl Acad Sci USA.
83:822–826. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mill JF, Chao MV and Ishii DN: Insulin,
insulin-like growth factor II, and nerve growth factor effects on
tubulin mRNA levels and neurite formation. Proc Natl Acad Sci USA.
82:7126–7130. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Recio-Pinto E, Lang FF and Ishii DN:
Insulin and insulin-like growth factor II permit nerve growth
factor binding and the neurite formation response in cultured human
neuroblastoma cells. Brain Res. 81:2562–2566. 1984.
|
|
27
|
Qi J, Shi LY, Wu Y, Shen XJ, Yuan J, Jin
CJ, Cong H and Ju SQ: Epigenetic silencing of miR-335 induces
migration by targeting insulin-like growth factor-1 receptor in
multiple myeloma. Leuk Lymphoma. 1–11. Jun 13–2019.Epub ahead of
print.
|
|
28
|
Ren L, Yao Y, Wang Y and Wang S: MiR-505
suppressed the growth of hepatocellular carcinoma cells via
targeting IGF-1R. Biosci Rep. 39:pii: BSR201824422019. View Article : Google Scholar
|
|
29
|
Cui Y, Sun X, Jin L, Yu G, Li Q, Gao X, Ao
J and Wang C: MiR-139 suppresses β-casein synthesis and
proliferation in bovine mammary epithelial cells by targeting the
GHR and IGF1R signaling pathways. BMC Vet Res. 13:3502017.
View Article : Google Scholar
|
|
30
|
Nam RK, Benatar T, Wallis CJD, Kobylecky
E, Amemiya Y, Sherman C and Seth A: MicroRNA-139 is a predictor of
prostate cancer recurrence and inhibits growth and migration of
prostate cancer cells through cell cycle arrest and targeting IGF1R
and AXL. Prostate. 79:1422–1438. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yuan SM, Guo Y, Wang Q, Xu Y, Wang M, Chen
HN and Shen WM: Overexpression of PPAR-γ2 gene enhances the
adipogenic differentiation of hemangioma-derived mesenchymal stem
cells in vitro and in vivo. Oncotarget. 8:115817–115828. 2017.
View Article : Google Scholar
|
|
32
|
Holly J, Sabin M, Perks C and Shield J:
Adipogenesis and IGF-1. Metab Syndr Relat Disord. 4:43–50. 2006.
View Article : Google Scholar
|
|
33
|
Maoa R, Zou F, Yang L, Lin S, Li Y, Ma M,
Yin P, Liang X and Liu J: The loss of MiR-139-5p promotes
colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt
signaling. Int J Biochem Cell Biol. 69:153–161. 2015. View Article : Google Scholar
|
|
34
|
Xu J and Liao K: Protein kinase B/AKT 1
plays a pivotal role in insulin-like growth factor-1 receptor
signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem.
279:35914–35922. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gagnon A, Chen CS and Sorisky A:
Activation of protein kinase B and induction of adipogenesis by
insulin in 3T3-L1 preadipocytes: Contribution of
phosphoinositide-3,4,5-trisphosphate versus
phosphoinositide-3,4-bisphosphate. Diabetes. 48:691–698. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kohn AD, Summers SA, Birnbaum MJ and Roth
RA: Expression of a constitutively active Akt Ser/Thr kinase in
3T3-L1 adipocytes stimulates glucose uptake and glucose transporter
4 translocation. J Biol Chem. 271:31372–31378. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Magun R, Burgering BM, Coffer PJ,
Pardasani D, Lin Y, Chabot J and Sorisky A: Expression of a
constitutively activated form of protein kinase B (c-Akt) in 3T3-L1
preadipose cells causes spontaneous differentiation. Endocrinology.
137:3590–3593. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peng XD, Xu PZ, Chen ML, Hahn-Windgassen
A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman
KG and Hay N: Dwarfism, impaired skin development, skeletal muscle
atrophy, delayed bone development, and impeded adipogenesis in mice
lacking Akt1 and Akt2. Gene Dev. 17:1352–1365. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tomiyama K, Nakata H, Sasa H, Arimura S,
Nishio E and Watanabe Y: Wortmannin, a specific
phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic
differentiation of 3T3-L1 cells. Biochem Bioph Res Commun.
212:263–269. 1995. View Article : Google Scholar
|
|
40
|
Cai R, Tang G, Zhang Q, Yong W, Zhang W,
Xiao J, Wei C, He C, Yang G and Pang W: A novel lnc-RNA, named
lnc-ORA, is identified by RNA-seq analysis, and its knockdown
inhibits adipogenesis by regulating the PI3K/AKT/mTOR signaling
pathway. Cells. 8:pii: E4772019. View Article : Google Scholar
|
|
41
|
Mi L, Chen Y, Zheng X, Li Y, Zhang Q, Mo D
and Yang G: MicroRNA-139-5p suppresses 3T3-L1 preadipocyte
differentiation through Notch and IRS1/PI3K/Akt insulin signaling
pathways. J Cell Biochem. 116:1195–1204. 2015. View Article : Google Scholar
|
